Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Research crawled time : 13:20 save search
UNVEILING THE VOICE OF GEN Z HISPANICS IN COLLEGE: 2ND ANNUAL LATINE RESEARCH STUDY DELIVERS POWERFUL INSIGHTS ON AI, GUN OWNERSHIP, MENTAL HEALTH, SEX AND POLITICS
Published: 2023-08-22 (Crawled : 13:20) - prnewswire.com
MTCH | $31.685 -0.86% -0.87% 3.4M
|
Technology Services
|
| O: 1.21%
H: 1.48%
C: -0.23%
gen research study
Enveric Biosciences Completes Manufacturing of EB-373 to Supply Drug Material for Completion of Preclinical Program
Published: 2023-08-21 (Crawled : 13:20) - biospace.com/
ENVB | $0.899 4.41% 4.23% 71K
|
Health Technology
|
| O: 6.05%
H: 3.07%
C: 1.32%
eb-373 drug preclinical program
IceCure Medical Continues to Experience Growing Global Interest in ProSense: Featured at the 16th Thai Breast Symposium
Published: 2023-08-21 (Crawled : 13:20) - biospace.com/
TRUMF | $16.488 -17.59% 1.7K
|
Health Technology
|
| O: -4.66%
H: 2.92%
C: -0.06%
TRUMY | $16.94 0.79% 52K
|
Manufacturing
|
| O: -0.99%
H: 2.25%
C: 0.39%
breast symposium global growing medical
Gilead Announces Partial Clinical Hold for Magrolimab Studies in AML
Published: 2023-08-21 (Crawled : 13:20) - biospace.com/
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: -0.28%
H: 0.78%
C: 0.36%
aml
Inhibikase Therapeutics Initiates Development of Second Generation c-Abl inhibitors and names IkT-148009 as risvodetinib
Published: 2023-08-21 (Crawled : 13:20) - biospace.com/
IKT | $1.57 14.6% 12.74% 78K
|
Health Technology
|
| O: 5.07%
H: 4.38%
C: -0.22%
ikt-148009 c-abl therapeutics
Valvoline Instant Oil ChangeSM supports cancer research and patient care at Dana-Farber Cancer Institute
Published: 2023-08-01 (Crawled : 13:20) - globenewswire.com
VVV | $42.23 0.96% 0.0% 770K
|
Process Industries
|
| O: -0.24%
H: 0.87%
C: -1.0%
institute cancer care research
Jazz Pharmaceuticals Receives CHMP Positive Opinion for JZP458 (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Published: 2023-07-21 (Crawled : 13:20) - biospace.com/
JAZZ | $109.685 0.79% 0.78% 380K
|
Health Technology
|
| O: 0.06%
H: 2.72%
C: 2.14%
jzp458 chmp positive treatment pharmaceuticals leukemia
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction
Published: 2023-07-21 (Crawled : 13:20) - biospace.com/
MRK | $126.88 -0.05% -0.13% 7.5M
|
Health Technology
|
| O: 0.25%
H: 1.73%
C: 1.53%
keytruda chmp merck positive treatment plus
Merck Receives Positive European Union CHMP Opinion for Gefapixant
Published: 2023-07-21 (Crawled : 13:20) - biospace.com/
MRK | $126.88 -0.05% -0.13% 7.5M
|
Health Technology
|
| O: 0.25%
H: 1.73%
C: 1.53%
chmp merck positive
Prothena Presents New Research in the Treatment of Alzheimer’s Disease at Alzheimer’s Association International Conference® 2023 (AAIC®)
Published: 2023-07-17 (Crawled : 13:20) - biospace.com/
PRTA 4 | $20.565 -3.41% -3.53% 440K
|
Health Technology
|
| O: 0.0%
H: 4.46%
C: 0.84%
conference disease association alzheimer’s international treatment research
BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities
Published: 2023-07-07 (Crawled : 13:20) - biospace.com/
BRTX | $1.35 -2.17% -2.22% 89K
|
Professional, Scientific, and T...
|
| O: 0.49%
H: 1.93%
C: -7.71%
brtx-100 drug candidate test pipeline
Phil and RedHill Biopharma Partner to Increase Access to Talicia®
Published: 2023-07-06 (Crawled : 13:20) - biospace.com/
RDHL | $0.4277 -3.32% -3.44% 470K
|
Health Technology
|
| O: -0.81%
H: 5.74%
C: 2.7%
talicia biopharma
Atossa Therapeutics Announces Sponsored Research Agreement with Weill Cornell Medicine to Address Treatment Challenges in Triple Negative Breast Cancer
Published: 2023-07-06 (Crawled : 13:20) - globenewswire.com
ATOS | $1.485 4.58% 4.38% 1.1M
|
Health Technology
|
| O: 0.83%
H: 1.65%
C: 1.65%
breast cancer treatment research therapeutics agreement negative
New Research Shows Simufilam Suppresses Overactive mTOR
Published: 2023-06-27 (Crawled : 13:20) - globenewswire.com
SAVA M | $20.54 0.19% 0.19% 500K
|
Health Technology
|
| O: 0.8%
H: 1.97%
C: 0.84%
research
Nascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual Meeting
Published: 2023-06-07 (Crawled : 13:20) - biospace.com/
NBIO | $0.0898 15.32% 190K
|
|
| O: 0.0%
H: 7.56%
C: 7.56%
biotech meeting
MAIA Biotechnology Files Second Patent For New Telomere-Targeting Molecules Program
Published: 2023-06-07 (Crawled : 13:20) - biospace.com/
MAIA | $2.46 8.85% 0.41% 240K
|
|
| O: 3.33%
H: 0.0%
C: -5.08%
patent program
Ocular Therapeutix™ Completes Enrollment of the HELIOS Clinical Trial of OTX-TKI for the Treatment of Diabetic Retinopathy Interim 6-month Data Expected in the First Quarter of 2024
Published: 2023-06-07 (Crawled : 13:20) - biospace.com/
OCUL | News | $5.0 -1.48% -1.5% 2.3M
|
Health Technology
|
| O: 0.39%
H: 0.91%
C: -3.39%
ocular expected treatment trial diabetic
Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 in Women Diagnosed with Menopausal Hot Flashes
Published: 2023-06-07 (Crawled : 13:20) - biospace.com/
VTGN | $4.83 1.05% 1.04% 190K
|
Health Technology
|
| O: 9.21%
H: 0.0%
C: -16.87%
ph80 positive women results study
Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device
Published: 2023-06-05 (Crawled : 13:20) - biospace.com/
AVGR | $3.785 -7.67% 3.3K
|
Health Technology
|
| O: 0.36%
H: 9.07%
C: 7.27%
device total
Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0
Published: 2023-06-05 (Crawled : 13:20) - biospace.com/
CWBR | $0.9004 -11.88% 1.1K
|
Health Technology
|
| O: 6.64%
H: 8.85%
C: -11.48%
positive trial results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.